← Leaderboards
Robert Frank Debusk
Stanford University
$2,255,779
Attributed
$2,255,779
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$2,255,779 · 3
By mechanism
R01$2,099,657 · 2
N01$156,122 · 1
Top collaborators
No co-investigators on record.
Most similar at Stanford University
Same institution · by research overlap
- Alan F Schatzberg$23,769,347
- Peter Rudd$1,985,482
- Gillian D Sanders$0
- Sanjiv M Narayan$16,082,773
- Luis De Lecea$21,616,243
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectBehavioral /Social Science Research TagHuman Therapy EvaluationTherapy ComplianceNursing InterventionCardiovascular Disorder ChemotherapyTelemedicineHypertensionPatient Oriented ResearchMedically Underserved PopulationCounselingOutcomes ResearchPatient Monitoring DeviceClinical TrialsDepressionElectrocardiographyGender DifferenceHealth BehaviorHealth EducationIsolation /DeprivationMyocardial InfarctionPsychosocial RehabilitationPsychosocial SeparationQuality Of Life
Grant awards (6)
New Strategies to Enhance Drug Adherence in Hypertension$493,697
R01 · FY2003 · HL
New Strategies to Enhance Drug Adherence in Hypertension$583,156
R01 · FY2002 · HL
New Strategies to Enhance Drug Adherence in Hypertension$525,981
R01 · FY2001 · HL
ENRICHD$0
N01 · FY2001 · HC
EFFICACY OF A HEART FAILURE MANAGEMENT SYSTEM$496,823
R01 · FY2000 · HL
ENRICHD$156,122
N01 · FY2000 · HC